Position
Fidelity in Allogene Therapeutics, Inc.
Back to the book · All holders of ALLO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$572.3K$2.44 → $2.08
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.45M | $1.98M | — | — | — | 0.0% |
| Q1 2026 | 1.59M | $3.88M | $2.44 | $1.55M | $351.5K | 0.0% |
| Q2 2026 | 12M | $25M | $2.08 | −$572.3K | $21.7M | 0.0% |